Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01510912 · ClinicalTrials.gov registry record · Phase 3
Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain
A Phase 3 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 602
- Enrollment target
NCT01510912 is a Phase 3 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 602 participants.
The verdict
NCT01510912, a Phase 3 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 602 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of Diclofenac \[Test\] Capsules for the treatment of osteoarthritis pain of the knee or hip.
Interventions
- DRUG Diclofenac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01510912
The ClinicalTrials.gov registry entry for NCT01510912 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diclofenac is the first listed.
NCT01510912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01510912 about?
NCT01510912 is a clinical study titled "Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain". The purpose of this study is to evaluate the safety of Diclofenac \[Test\] Capsules for the treatment of osteoarthritis pain of the knee or hip.
What is the current status of trial NCT01510912?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 602 participants. The study started on 2012-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01510912?
The interventions under investigation include: Diclofenac (DRUG).
Who is sponsoring clinical trial NCT01510912?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.